ArticleOncogene2018
Proteomic profiling identifies key coactivators utilized by mutant ERα proteins as potential new therapeutic targets.
Leah A Gates et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
49 papers cite it
this papercites it